Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Pediatric Blood & Cancer|June 21, 2022
Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortiumEric S Schafer, Karen Chao, Alexandra M Stevens, et al.
Pediatric Blood & Cancer|July 23, 2024
Toxicity profile of high-dose methotrexate in young children with central nervous system tumorsAshley N Chavana, Zachary L Taylor, Nicholas DeGroote, et al.
Pediatric Blood & Cancer|November 15, 2019
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)Eric S Schafer, Rachel E Rau, Stacey L Berg, et al.
Experimental Parasitology|September 21, 2016
Melaleuca alternifolia anthelmintic activity in gerbils experimentally infected by Haemonchus contortusThirssa H Grando, Matheus D Baldissera, Lucas T Gressler, et al.
Scientific Reports|October 18, 2023
Use of transcranial low-intensity focused ultrasound for targeted delivery of stem cell-derived exosomes to the brainJ Haroon, K Aboody, L Flores, et al.
Clinical and Translational Science|July 28, 2023
Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.orgZachary L Taylor, Tamara P Miller, Ethan A Poweleit, et al.
Pathology, Research and Practice|December 3, 2014
Relationship between oxidative stress and pathological findings in abomasum of infected lambs by Haemonchus contortusVanessa Machado, Aleksandro S Da Silva, Andressa S Schafer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 4, 2016
Nerolidol-loaded nanospheres prevent behavioral impairment via ameliorating Na+, K+-ATPase and AChE activities as well as reducing oxidative stress in the brain of Trypanosoma evansi-infected miceMatheus D Baldissera, Carine F Souza, Thirssa H Grando, et al.
Cancers|February 10, 2024
Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) ConsortiumAnupam Verma, Yueh-Yun Chi, Jemily Malvar, et al.
Haematologica|February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.
Pageof 9